✦ LIBER ✦

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers

✍ Scribed by Caron, C; Lestrat, C; Marsal, S; Escoffier, E; Curtet, S; Virolle, V; Barbry, P; Debernardi, A; Brambilla, C; Brambilla, E

Book ID: 109972442
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 761 KB
Volume: 29
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2010.259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thermography as a predictor of prognosis

Thermography as a predictor of prognosis in cancer of the breast

✍ Ernest E. Sterns; Benny Zee 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 2 views

Quantitative ultrasound as a predictor o

Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer

✍ Hideyuki Hashimoto; Masato Suzuki; Masaki Oshida; Takeshi Nagashima; Hiroshi Yag 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 865 KB

Aldehyde dehydrogenase 1 expression is a

Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study

✍ Takako Yoshioka; Yoshihisa Umekita; Yasuyo Ohi; Masakazu Souda; Yoshiatsu Sagara 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Clinical significance of Ki-67 in neoadj

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

✍ Reiki Nishimura; Tomofumi Osako; Yasuhiro Okumura; Mitsuhiro Hayashi; Nobuyuki A 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 316 KB

Serum matrix metalloproteinase-2 and its

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension

✍ Kazuo Gohji; Noboru Fujimoto; Isao Hara; Akio Fujii; Akinobu Gotoh; Hiroshi Okad 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 2 views

We examined whether the serum matrix metalloproteinase-2 (MMP-2) level and MMP-2 density could be predictors of the development and extension of prostate cancer. Serum samples were collected before any clinical treatment from 98 patients with prostate cancer and from 76 patients with benign prostati

Phase 2 study of gemcitabine and irinote

Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response

✍ Stacy Moulder; Nickola Valkov; Anthony Neuger; Jimin Choi; Ji Hyun Lee; Susan Mi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB